Blog

Having good indoor air quality is an important part of living in a healthy home. You can improve your indoor air quality by reducing the sources of allergens and irritants in your home. "We take about 20,000 breaths each day and spend 90% of our time indoors. Now that we are in a global pandemic from the new coronavirus (COVID-19) with stay-at-home orders, this rate of staying indoors has increased. Reducing exposure to substances in the environment around us that trigger allergy and asthma...

More than 65 million people in the United States live with asthma or allergies to food , drugs or other allergens . About 3,600 people die each year from asthma – deaths that can often be prevented . COVID-19 (the new coronavirus) poses even more danger to people with asthma and allergies. To kick off National Asthma and Allergy Awareness Month and for World Asthma Day , the Asthma and Allergy Foundation of America (AAFA) and the MedicAlert Foundation have partnered to raise awareness and...

The Asthma and Allergy Foundation of America (AAFA) has been fighting to save lives for nearly 70 years. With your support, we provide education, conduct patient-centered research and advocate for protections for our community. Our experience and strong community ties allowed us to take prompt action on the COVID-19 crisis . Thanks to your generous support, we are leading the fight against COVID-19 for people with asthma and allergies. But we need your help to continue to provide COVID-19...

Congressmen Eliot L. Engel (D-NY) and Fred Upton (R-MI), Co-Chairs of the Asthma and Allergy Caucus, joined by Congressmen TJ Cox (D-CA) and Peter King (R-NY), Members of Caucus, led 57 Members of the House on a letter to the Food and Drug Administration (FDA) about shortages of albuterol inhalers, which are critical to effective asthma management.

Join the MedicAlert Foundation and Kenneth Mendez, CEO and president of the Asthma and Allergy Foundation of America (AAFA), for a webinar on how people with asthma and allergies can protect themselves during COVID-19 (the new coronavirus).

Learn about asthma management from top experts and patients at AsthmaCon, a free virtual asthma conference, now through June 30, 2020.

The Asthma and Allergy Foundation of America is sharing this message from the American College of Allergy, Asthma and Immunology (ACAAI)for people with asthma about a shortage of albuterol metered dose inhalers

The U.S. Food and Drug Administration today approved the first generic of Proventil HFA (albuterol sulfate) Metered Dose Inhaler, 90 mcg/Inhalation, for the treatment or prevention of bronchospasm in patients four years of age and older who have reversible obstructive airway disease, as well as the prevention of exercise-induced bronchospasm in this age group.

Because of the COVID-19 (new coronavirus) pandemic, we are facing a challenging and unprecedented time. COVID-19 is a respiratory infection, and the nearly 25 million Americans with asthma are at high risk for complications from the virus. As the leading patient organization for people with asthma and allergies, this has the Asthma and Allergy Foundation of America (AAFA) deeply concerned for your health and well-being.

Update: On Dec. 2, 2020, the Department of Transportation (DOT) posted their final rule on “ Traveling by Air with Service Animals .” The rule will allow airlines to treat emotional support animals as pets. The DOT acknowledged AAFA’s comments. They said they felt the rule will likely reduce the number of uncrated animals on planes, so that would reduce the number of potential allergic reactions and asthma episodes. AAFA expressed support for the core proposal. But we are disappointed that...

The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperature

With the current spread of the new coronavirus (COVID-19) in the U.S. and around the world, many people with asthma wonder how it would affect them if they got the illness. There is a lot we still don't know about this illness. Dr. Mitchell Grayson, the chair of the Asthma and Allergy Foundation of America's (AAFA) Medical Scientific Council, wrote this article for our blog about what we do know at this time. There have been many questions about how having asthma affects your risk of getting...